[Cyclophosphamide as induction treatment in ANCA+ vasculitis affecting the kidneys: intravenous or oral pulses, or daily oral doses?]
- PMID: 20221223
- DOI: 10.3265/NEFROLOGIA.2009.29.S.E.noID.36.free
[Cyclophosphamide as induction treatment in ANCA+ vasculitis affecting the kidneys: intravenous or oral pulses, or daily oral doses?]
Comment on
-
Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.Ann Intern Med. 2009 May 19;150(10):670-80. doi: 10.7326/0003-4819-150-10-200905190-00004. Ann Intern Med. 2009. PMID: 19451574 Clinical Trial.
Similar articles
-
Daily oral versus pulse intravenous cyclophosphamide in the therapy of ANCA-associated vasculitis--preliminary single center experience.Prague Med Rep. 2004;105(1):64-8. Prague Med Rep. 2004. PMID: 15354947 Clinical Trial.
-
Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study.Arthritis Rheum. 1998 Oct;41(10):1835-44. doi: 10.1002/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q. Arthritis Rheum. 1998. PMID: 9778225 Clinical Trial.
-
[ANCA(antineutrophil cytoplasmic antibodies)-associated vasculitis in a man with extreme fatigue, fever and progressive renal dysfunction].Ned Tijdschr Geneeskd. 2008 Apr 26;152(17):1009-14. Ned Tijdschr Geneeskd. 2008. PMID: 18549177 Dutch.
-
[ANCA-associated vasculitis].G Ital Nefrol. 2002 Mar-Apr;19(2):125-36. G Ital Nefrol. 2002. PMID: 12195410 Review. Italian.
-
Treatment of ANCA-associated systemic vasculitis.Bull NYU Hosp Jt Dis. 2006;64(1-2):60-6. Bull NYU Hosp Jt Dis. 2006. PMID: 17121492 Review.
Publication types
LinkOut - more resources
Full Text Sources